Development of Epitope-Blocking ELISA for Universal Detection of Antibodies to Human H5N1 Influenza Viruses
2009

New Test for Detecting H5N1 Influenza Antibodies

Sample size: 45 publication 10 minutes Evidence: high

Author Information

Author(s): Prabakaran Mookkan, Ho Hui-Ting, Prabhu Nayana, Velumani Sumathy, Szyporta Milene, He Fang, Chan Kwai-Peng, Chen Li-Mei, Matsuoka Yumiko, Donis Ruben O., Kwang Jimmy

Primary Institution: Temasek Life Sciences Laboratory, National University of Singapore

Hypothesis

Can an epitope-blocking ELISA effectively detect antibodies to H5N1 influenza viruses in human and animal sera?

Conclusion

The epitope-blocking ELISA provided highly sensitive and specific detection of antibodies to H5N1 influenza viruses in human sera.

Supporting Evidence

  • The epitope recognized by the mAb is conserved in 100% of the 163 H5N1 viruses isolated from humans.
  • The assay showed higher sensitivity and specificity compared to hemagglutinin inhibition and microneutralization assays.
  • The 5F8 mAb-based EB-ELISA detected H5N1 antibodies in convalescent human sera with a mean percent blocking of 73.16.

Takeaway

Scientists created a new test to find out if people have antibodies against a specific bird flu virus called H5N1. This test works really well and can tell the difference between H5N1 and other flu viruses.

Methodology

The study developed an epitope-blocking ELISA using a monoclonal antibody to detect specific antibodies in human and animal sera.

Limitations

The assay may not distinguish between HPAI H5N1 and low pathogenic H5 subtypes in animals.

Participant Demographics

The study included 45 human serum samples from individuals with known H5N1 exposure history.

Digital Object Identifier (DOI)

10.1371/journal.pone.0004566

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication